Cargando…

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis

BACKGROUND: Cardiovascular risk is increased in transgender persons using gender-affirming hormone therapy. To gain insight into the mechanism by which sex hormones affect cardiovascular risk in transgender persons, we investigated the effect of hormone therapy on markers of inflammation and hemosta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schutte, Moya H., Kleemann, Robert, Nota, Nienke M., Wiepjes, Chantal M., Snabel, Jessica M., T’Sjoen, Guy, Thijs, Abel, den Heijer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923509/ https://www.ncbi.nlm.nih.gov/pubmed/35290388 http://dx.doi.org/10.1371/journal.pone.0261312

Ejemplares similares

Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Matthys, Imke, et al.
Publicado: (2021)

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
por: Scheres, Luuk J.J., et al.
Publicado: (2021)

Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
por: Klaver, Maartje, et al.
Publicado: (2021)

Gender affirming hormonal treatment in Danish transgender persons: A nationwide register‐based study
por: Glintborg, Dorte, et al.
Publicado: (2022)

Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018)

The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives
por: Cocchetti, Carlotta, et al.
Publicado: (2022)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

Change in grip strength in trans people and its association with lean body mass and bone density
por: Scharff, Miranda, et al.
Publicado: (2019)

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
por: van der Loos, Maria ATC, et al.
Publicado: (2021)

SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Defreyne, Justine, et al.
Publicado: (2020)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
por: van Velzen, Daan, et al.
Publicado: (2021)

Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study
por: de Nie, Iris, et al.
Publicado: (2021)

The Role of Estrone in Feminizing Hormone Treatment
por: Tebbens, Marieke, et al.
Publicado: (2021)

Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy
por: Collet, Sarah, et al.
Publicado: (2022)

Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people: a protocol for a scoping review
por: Van den Bosch, M. F., et al.
Publicado: (2021)

ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery”
por: Özer, Müjde, et al.
Publicado: (2021)

Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023)

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
por: de Blok, Christel J M, et al.
Publicado: (2019)

Magnetic Resonance Spectroscopy in Gender Dysphoria
por: Collet, Sarah Marie, et al.
Publicado: (2021)

Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
por: Cocchetti, C., et al.
Publicado: (2022)

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long Term Follow up Study on Prevalence, Determinants, and the Effect of Years of Exposure
por: Madsen, Milou Cecilia, et al.
Publicado: (2021)

OR27-05 Sexual Desire Changes in Transgender Individuals upon Initiation of Hormone Treatment; Results from the Longitudinal ENIGI Study
por: Defreyne, Justine, et al.
Publicado: (2020)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

Frequency and Characteristics of Postoperative Neuropathy in Individuals on Gender-Affirming Hormone Therapy Undergoing Gender Affirmation Surgery: A Retrospective Cohort Study
por: Togioka, Brandon M, et al.
Publicado: (2023)

Localized Rhabdomyolysis Associated With Testosterone Enanthate for Gender-Affirming Hormonal Therapy
por: Reddy, Rashmi, et al.
Publicado: (2022)

Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972–2017)
por: Wiepjes, C. M., et al.
Publicado: (2020)

Characterization of the (1)H-MRS Metabolite Spectra in Transgender Men with Gender Dysphoria and Cisgender People
por: Collet, Sarah, et al.
Publicado: (2021)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023)

100. Patterns of Perioperative Hormone Therapy for Gender-affirming Surgery
por: Hung, Ya-Ching, et al.
Publicado: (2023)

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years
por: Madsen, Milou Cecilia, et al.
Publicado: (2021)

Gender Affirmation Surgery
por: Selvaggi, Gennaro, et al.
Publicado: (2018)

Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
por: Connelly, Paul J., et al.
Publicado: (2019)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_llnanb8ijscvqmnu1d6mieh035